By Jaden Choi — a plain-English look at what decades of research actually show about the most popular pill in America.

Roughly one in three American adults takes a multivitamin, mostly as a kind of nutritional insurance policy — a hedge against whatever the diet misses. So it's a fair question to ask what you're actually buying. Here's the honest, up-front answer: for a reasonably well-nourished adult, a daily multivitamin has not been shown to prevent heart disease, cancer, or early death. But "does nothing" is too blunt — the research is genuinely split by what you're hoping it does, and a couple of recent findings make the picture more interesting than "worthless" or "miracle."

Let's walk through what the largest trials and cohort studies really found — including a study that followed nearly 400,000 people for two decades — separate the outcomes that didn't move from the one or two that did, and sort out why the headlines seem to flip every year.

The short answer — it depends what you're asking it to do

Most of the confusion around multivitamins comes from lumping very different questions together. "Does a multivitamin work?" isn't one question — it's at least four: Will it help me live longer? Prevent heart disease or cancer? Protect my brain? Or correct a nutrient I'm actually missing? The research gives different answers to each.

The strongest, most consistent finding is the disappointing one: for an average, adequately fed adult, taking a daily multivitamin does not meaningfully lower the risk of the big outcomes — dying sooner, having a heart attack, or developing cancer. That's not one study's opinion; it's the conclusion of an independent expert panel that reviewed the whole body of evidence.

For preventing heart disease and cancer: not much

In 2022, the US Preventive Services Task Force (USPSTF) — the independent panel whose recommendations shape US preventive care — published its updated review in JAMA. After weighing the trial evidence, it issued an "I statement": the current evidence is insufficient to say multivitamins prevent cardiovascular disease or cancer. In plainer terms, there simply isn't good reason to take one for that purpose.

The same review went further on two specific ingredients. It recommended against taking beta-carotene — because in people at high risk of lung cancer (like smokers), it was linked to a higher risk — and against vitamin E, which showed no benefit. That's a useful reminder that "more nutrients" is not automatically safer; a few can do harm at supplement doses.

The mortality question got its own answer in 2024. Researchers at the National Cancer Institute pooled three large US cohorts — 390,124 generally healthy adults — and tracked them for more than two decades, during which over 164,000 people died. Their finding, published in JAMA Network Open: daily multivitamin users were no less likely to die — not from any cause, and not specifically from cancer, heart disease, or stroke. If anything, this is the closest thing to a definitive answer on longevity, and the answer is no.

The one cancer signal — and its asterisk

It would be dishonest to stop at "no benefit," because one high-quality trial found something. The Physicians' Health Study II, published in JAMA in 2012, was a randomized controlled trial — the gold standard — in 14,641 male physicians aged 50 and older, followed for about 11 years. Men taking a daily multivitamin had a statistically significant 8% lower rate of total cancer (hazard ratio 0.92) than those on placebo.

That's a real result from a well-run trial, and it's the strongest positive data multivitamins have. But read the asterisks honestly: the effect was modest, it didn't reduce deaths from cancer, it showed no benefit for any specific cancer site, and the participants were all male doctors — a group whose results don't automatically generalize to everyone. One promising trial next to several large studies showing nothing is why the expert consensus lands on "insufficient evidence" rather than "yes."

For your brain: a newer, more interesting story

The most intriguing recent development isn't about the heart or cancer — it's about memory. The COSMOS trials (COcoa Supplement and Multivitamin Outcomes Study) ran several randomized, placebo-controlled experiments in older adults. In COSMOS-Mind, published in Alzheimer's & Dementia in 2023, three years of a daily multivitamin improved global cognition compared with placebo — the researchers estimated it slowed cognitive aging by the equivalent of about 1.8 years.

A companion trial, COSMOS-Web (published in the American Journal of Clinical Nutrition, 2023), tested memory in 3,562 adults aged 60 and up and found a small but statistically significant benefit for memory over placebo. Pooled together, the COSMOS studies point in a consistent direction: a modest cognitive edge in older adults.

This is genuinely encouraging — but keep it in proportion. The effects were small, they were seen in people over 60 (not necessarily younger adults), the trials were partly industry-supported, and researchers themselves say the results need replication before anyone recommends multivitamins specifically for brain health. It's a promising lead, not a settled prescription.

What the major studies actually found

Because the headlines swing wildly depending on which study a reporter read that week, here's the whole landscape in one place. Notice how the answer tracks with what was being measured and in whom.

Results are simplified for comparison. "RCT" = randomized controlled trial (the strongest design); cohort studies observe existing users and are more prone to confounding. See Sources for full citations.

Where a multivitamin genuinely helps

Here's the part the "multivitamins are useless" headlines tend to skip: those studies were mostly done in generally well-nourished adults. The picture changes for people who are actually short on a nutrient — and that's a lot of people in specific situations. When there's a real gap, filling it isn't a marginal insurance play; it prevents genuine problems.

• Pregnancy or trying to conceive. Adequate folic acid before and during early pregnancy sharply reduces the risk of neural tube defects — this is one of the best-established supplement benefits in medicine, and prenatal vitamins exist for exactly this reason.
• Restrictive or vegan diets. Vitamin B12 comes almost entirely from animal foods, so people eating little or no animal product can fall short without a supplement.
• Older adults. Absorption of some nutrients (B12 in particular) declines with age, and appetite often shrinks, making gaps more common.
• Certain medical conditions or medications. Conditions that impair absorption (like celiac or after some bariatric surgeries) and some long-term medications can create real deficiencies that a clinician may address with supplements.

The through-line: a multivitamin earns its keep when it's correcting an actual shortfall, not when it's layered on top of an already-adequate diet. It also can't undo a poor diet — whole foods deliver fiber and hundreds of compounds no pill replicates.

Why the studies seem to contradict each other

If every year brings a headline that flips the last one, it's usually not that the science is broken — it's that different study designs answer different questions. Two ideas explain most of the whiplash.

First, randomized trials versus observational studies. RCTs (like PHS II and COSMOS) randomly assign people to a multivitamin or placebo, which is the only way to isolate cause and effect. Observational cohorts just watch who already takes vitamins — and vitamin-takers tend to be different (often more health-conscious, or sometimes sicker and taking them because they're unwell). That's called confounding, and it can push results in either direction.

Second, the population matters enormously. A benefit that's invisible in well-fed adults can be real in people with deficiencies, and a cognitive effect seen in 70-year-olds may not exist in 30-year-olds. When you see two studies "disagree," the first question to ask is: same design? same people? Usually the answer explains the gap.

So should you take one?

That's a decision for you and your doctor, not a blog — but the research does point to a sensible way to think about it. If your goal is to prevent heart disease, cancer, or an early death, the evidence says a multivitamin is unlikely to do that, and the money is better spent on the things that clearly work: a varied diet, physical activity, sleep, and not smoking.

If you're in one of the groups above with a real risk of a gap — pregnant, vegan, older, or managing a condition that affects absorption — a multivitamin or a targeted supplement can be genuinely worthwhile, ideally guided by a clinician who can check what you actually need. A daily multivitamin is generally considered low-risk for healthy adults (skip the beta-carotene-heavy or mega-dose formulas), so if it gives you peace of mind, it's unlikely to hurt. Just don't expect it to do the heavy lifting your diet and habits are supposed to do.

Frequently Asked Questions

Bottom Line — What the Science Says

Multivitamins occupy an odd middle ground: neither the wonder pill the label implies nor the pure waste of money the harshest headlines claim. The evidence sorts out cleanly once you separate the questions:

1. Not for prevention. For healthy adults, multivitamins don't meaningfully lower the risk of heart disease, cancer, or early death.
2. A couple of modest positives. One trial showed a small cancer reduction in older men; recent trials hint at slower memory decline after 60 — both promising, both unconfirmed.
3. Real value when there's a real gap. Pregnancy, restrictive diets, older age, and certain conditions are where a supplement genuinely helps.
4. No substitute for the basics. Diet, movement, and sleep do the heavy lifting a pill can't.

---

Sources

• US Preventive Services Task Force. "Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement." JAMA, 2022;327(23):2326–2333. PubMed
• Loftfield E, et al. "Multivitamin Use and Mortality Risk in 3 Prospective US Cohorts." JAMA Network Open, 2024;7(6):e2418729. PubMed
• Gaziano JM, et al. "Multivitamins in the Prevention of Cancer in Men: the Physicians' Health Study II Randomized Controlled Trial." JAMA, 2012;308(18):1871–1880. PubMed
• Baker LD, et al. "Effects of cocoa extract and a multivitamin on cognitive function: A randomized clinical trial (COSMOS-Mind)." Alzheimer's & Dementia, 2023;19(4):1308–1319. DOI: 10.1002/alz.12767
• National Institutes of Health, Office of Dietary Supplements. "Multivitamin/mineral Supplements — Consumer Fact Sheet." ods.od.nih.gov

This article summarizes published research for general educational purposes and is not medical advice. It does not diagnose, treat, or recommend any specific supplement, dose, or product for you personally. Individual nutrient needs vary, and some supplements can interact with medications or conditions. Research evolves and findings can be revised — talk to your doctor or a licensed healthcare provider before starting or stopping any supplement. Information is current as of September 2026.